Minerva Neurosciences, Inc. (NERV) stock
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.16−0.04 (-1.82%)
Close on Nov 17, 2026Market cap $103.14MP/E –Yield –
Minerva Neurosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Minerva Neurosciences's price to sales ratio was 1.9× on Jul 30, 2021.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jul 30, 2021 | 1.9× | −0.5 |
| 2020 | Dec 31, 2020 | 2.4× | – |
See a number that looks wrong?